Zyleris PharmaTech offers topical formulation development and screening service using our first-in-class high-throughput Franz Cell technology. The proprietary technology was developed based on industry standard Franz Cell principle. It offers best of both worlds - speed and cost efficiency associated with high-throughput experimentation, and data compatibility with the standard Franz Cell technology.Services provided:1. High-throughput skin absorption and penetration screening (IVPT).2. High-throughput in vitro release testing (IVRT).3. Topical formulation development and reverse engineering.4. Novel topical drug delivery technologies.In addition, Zyleris maintains active internal R&D programs. Up to date, Zyleris has developed two patent-pending technologies. One is a drug-release enhancement technology in topical formulations. The other is an IVRT method technology.